STOCK TITAN

NEOG insider Rafael Rodriguez converts 2,071 RSUs to shares

Filing Impact
(Low)
Filing Sentiment
(Positive)
Form Type
4

Rhea-AI Filing Summary

NEOGEN CORP (NEOG) director Rafael A. Rodriguez received 2,071 restricted stock units that vested and were settled into 2,071 shares of common stock on 10/07/2025. The reported per-share value on the transaction is $5.63, and Mr. Rodriguez's total beneficial ownership after the settlement is 17,019 shares held directly. The filing is a Form 4 disclosure of an insider vesting event rather than a market purchase or sale.

Positive

  • 2,071 RSUs vested and converted into 2,071 common shares on 10/07/2025
  • Direct beneficial ownership increased to 17,019 shares following settlement
  • Transaction was a vesting/settlement, indicating compensation alignment with shareholders rather than an insider sale

Negative

  • None.

Insights

Director vested RSUs converted to shares, modestly increasing direct stake.

The 2,071 restricted stock units became 2,071 common shares on 10/07/2025, increasing direct holdings to 17,019 shares. This is a routine compensation settlement that aligns executive pay with equity ownership.

The main dependency is the company's equity compensation schedule and vesting rules; there is no sale reported, so liquidity or tax-withholding actions are not disclosed. Watch upcoming Form 4s for any subsequent sales or open-market purchases within a short reporting window.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
RODRIGUEZ RAFAEL A

(Last) (First) (Middle)
620 LESHER PLACE

(Street)
LANSING MI 48912

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
NEOGEN CORP [ NEOG ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/07/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/07/2025 M 2,071 A $5.63 17,019 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units $5.63 10/07/2025 M 2,071 10/07/2025 10/07/2025 Common Stock 2,071 $5.63 0 D
Explanation of Responses:
Remarks:
Each RSU is the economic equivalent of one share of common stock. On October 7, 2025, these RSUs vested and were settled for an equal number of shares of common stock.
Christopher Sefcheck (Attorney in Fact) 10/09/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NEOG (NEOG) director Rafael A. Rodriguez report on Form 4?

He reported that 2,071 restricted stock units vested and were settled into 2,071 common shares on 10/07/2025 at an indicated value of $5.63 per share.

How many shares does Rafael A. Rodriguez beneficially own after the transaction?

The Form 4 reports a total of 17,019 shares beneficially owned directly after the RSU settlement.

Was this Form 4 entry an open-market purchase or sale for NEOG?

No. The filing shows a vesting/settlement of restricted stock units (code M), not an open-market purchase or sale.

What is the reported per-share value for the settled RSUs?

The filing lists a per-share price/value of $5.63 for the settled RSUs on 10/07/2025.

Did the Form 4 indicate any indirect ownership or group filing?

The filing indicates direct ownership and that the Form was filed by one reporting person; no indirect ownership was reported for these shares.
Neogen Corp

NASDAQ:NEOG

NEOG Rankings

NEOG Latest News

NEOG Latest SEC Filings

NEOG Stock Data

1.53B
215.36M
0.85%
112.78%
8.46%
Diagnostics & Research
In Vitro & in Vivo Diagnostic Substances
Link
United States
LANSING